Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER2 | P43116 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CLK1 | P49759 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ITK | Q08881 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | CTSA | P10619 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23725275 | 0.84 | ALDH1A1 (0.39) | ALDH1A1HPGDCLK1HTR7HTR1A | |
| SCHEMBL8768674 | 0.83 | CLK1 (0.40) | ALDH1A1HPGDCLK1HTR7HTR1A | |
| SCHEMBL1400663 | 0.77 | CLK1 (0.40) | ALDH1A1HPGDCLK1HTR7HTR1A | |
| SCHEMBL1110998 | 0.77 | HTR7 (0.42) | CLK1HTR7HTR1ADRD2HTR2A | |
| SCHEMBL8768703 | 0.76 | PTGER2 (0.39) | PTGER2EGFRTDP1GRM5NR4A2 | |
| SCHEMBL17846657 | 0.76 | HCRTR1 (0.46) | — | |
| SCHEMBL30438030 | 0.76 | HTR7 (0.42) | EGFRALDH1A1CLK1HTR7HTR1A | |
| SCHEMBL1812488 | 0.76 | HTR7 (0.42) | EGFRALDH1A1CLK1HTR7HTR1A | |
| SCHEMBL24323574 | 0.75 | HTR7 (0.41) | CLK1HTR7HTR1ADRD2HTR2A | |
| SCHEMBL15064925 | 0.75 | HTR7 (0.38) | ALDH1A1HPGDCLK1HTR7HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579908-B1 | Pyridyl derivatives, process for their preparation and their use as pesticides | BAYER AG (DE) | 1997-09-10 | — | — | EP | claimed |
| US-9066518-B2 | Heterocyclic compounds as pesticides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-30 | — | — | US | disclosed |
| US-20140221362-A1 | Heterocyclic Compounds as Pesticides | BAYER CROPSCIENCE AG (DE) | 2014-08-07 | — | — | US | disclosed |
| US-5196541-A | PROCESS FOR THE PREPARATION OF SUBSTITUTED 3-AMINOACRYLIC ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1993-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221362-A1 | Heterocyclic Compounds as Pesticides | DDT, ACHE, BCHE | PTGER2 3772/4885EGFR 4868/4885ALDH1A1 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.